http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014152282-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50d45dc45ba0704acf7632537250c5f9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0667 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-00 |
| filingDate | 2014-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30d987d0b8392b2457f27a5c781251d5 |
| publicationDate | 2014-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2014152282-A1 |
| titleOfInvention | Allogeneic stromal vascular fraction transplantation by blood type matching |
| abstract | Allogeneic transplantation of stromal vascular fraction for use in treating a disease, injury, or condition comprising matching the donor and recipient by blood type. The stromal vascular fraction may be derived from a vascularized tissue obtained from living and non-living sources ( e.g., post-mortem) using mechanical ( e.g., ultrasonic cavitation), enzymatic, and/or chemical treatment, wherein the tissue cells and blood vessels are lysed thereby releasing intact stromal vascular fraction cells while substantially maintaining the viability of the stromal vascular fraction. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2722055-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020117647-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11674131-B2 |
| priorityDate | 2013-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 69.